Study uncovers healthcare disparities among octogenarians and nonagenarians with advanced lung cancer

January 8, 2018, Wiley

A new study reveals that, among patients of advanced age with stage III lung cancer, African Americans and individuals who live in lower income areas are more likely to not receive any treatment. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study also found that patients who receive the standard of care treatment for their cancer live longer.

Individuals in their 80s and 90s may not receive standard of care therapy for lung due to their age and concerns about fragility. To gain insights on how octogenarian and nonagenarian patients are treated and how they fare, Richard Cassidy, MD, of the Winship Cancer Institute of Emory University, and his colleagues examined information on U.S. patients aged 80 years and older with stage III non-small cell lung cancer from 2004-2013 who had complete treatment records available in the National Cancer Data Base.

Among 12,641 patients, 7921 (62.7 percent) received no therapy. Black race and living in a lower-educated census-tract were linked with a 23 percent and 20 percent increased likelihood of not receiving care, respectively, while treatment at an academic center was associated with a 20 percent increased likelihood of receiving cancer-directed therapy. Patients who received no treatment or only radiation were more likely to die during the years analyzed than those receiving concurrent chemotherapy and radiation, the standard of care for stage III non-small cell lung cancer.

"Our study is the largest to look at patients 80 years and older with stage III lung cancer. We highlight risks for patients not receiving standard therapy and show that who receive standard care live longer," said Dr. Cassidy. "Our study also highlights healthcare disparities in the oncology community and showcases a need for the oncology community to address. This may provide information to guide outreach programs to engage the elderly community in seeking appropriate therapy for stage III ."

Explore further: Small-cell lung cancer patients face barriers to receiving standard-of-care treatment

More information: "Healthcare disparities among octogenarians and nonagenarians with stage III lung cancer." Cancer (2018). DOI: 10.1002/cncr.31077

Related Stories

Small-cell lung cancer patients face barriers to receiving standard-of-care treatment

January 4, 2018
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients ...

Not all 80-, 90-year-olds with rectal cancer are treated

August 4, 2017
(HealthDay)—About 15 percent of octogenarians and nonagenarians with stage II/III rectal adenocarcinoma do not receive treatment, according to a study published online July 31 in Cancer.

Proton therapy may be better option for elderly patients with esophageal cancer

October 25, 2017
A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with ...

Race, hospital, insurance status all factors in how lung cancer is treated

November 17, 2014
African Americans, Hispanics, and those who receive care at a community hospital are all significantly less likely than other patients to receive treatment for early stage non-small cell lung cancer, according to a report ...

More early stage lung cancer patients survive the disease

October 26, 2017
With the advancement of surgical and radiation therapy strategies for stage 1 non-small-cell lung cancer (NSCLC), more patients are being treated, resulting in higher survival rates, according to a study published online ...

Radiation therapy use low in end-stage cancer

January 13, 2013
(HealthDay)—Although the overall use of radiation treatment among elderly end-stage cancer patients is low during their final month of life, many receive more than 10 days of treatment, according to a study published in ...

Recommended for you

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.